Risk compensation after COVID‐19 vaccination: Evidence from vaccine rollout by exact birth date in South Korea DOI Creative Commons
Jisoo Hwang, Seung-Sik Hwang, Hyuncheol Bryant Kim

et al.

Health Economics, Journal Year: 2024, Volume and Issue: 33(8), P. 1811 - 1830

Published: May 10, 2024

We utilize the phased rollout of COVID-19 vaccines by exact birth date in South Korea as a natural experiment for testing risk compensation. People may resume face-to-face social activities following vaccination because they perceive lower infection. Applying regression discontinuity design based on cutoffs vaccine eligibility, we find no evidence risk-compensating behaviors, measured large, high-frequency data from credit card and airline companies well survey data. some self-selection into take-up perception toward effectiveness side effects, but treatment effects do not differ between compliers never-takers.

Language: Английский

Risk compensation after COVID‐19 vaccination: Evidence from vaccine rollout by exact birth date in South Korea DOI Creative Commons
Jisoo Hwang, Seung-Sik Hwang, Hyuncheol Bryant Kim

et al.

Health Economics, Journal Year: 2024, Volume and Issue: 33(8), P. 1811 - 1830

Published: May 10, 2024

We utilize the phased rollout of COVID-19 vaccines by exact birth date in South Korea as a natural experiment for testing risk compensation. People may resume face-to-face social activities following vaccination because they perceive lower infection. Applying regression discontinuity design based on cutoffs vaccine eligibility, we find no evidence risk-compensating behaviors, measured large, high-frequency data from credit card and airline companies well survey data. some self-selection into take-up perception toward effectiveness side effects, but treatment effects do not differ between compliers never-takers.

Language: Английский

Citations

1